-
1
-
-
0018164274
-
Platinum nephrotoxicity
-
99034 10.1016/0002-9343(78)90825-2 1:CAS:528:DyaE1cXltVWjsbc%3D
-
Madias NE, Harrington JT (1978) Platinum nephrotoxicity. Am J Med 65(2):307-314
-
(1978)
Am J Med
, vol.65
, Issue.2
, pp. 307-314
-
-
Madias, N.E.1
Harrington, J.T.2
-
2
-
-
0018241876
-
A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment
-
751721 1:STN:280:DyaE1M7ovFGrtA%3D%3D
-
Cavalli F, Tschopp L, Sonntag RW, Zimmermann A (1978) A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment. Cancer Treat Rep 62(12):2125-2126
-
(1978)
Cancer Treat Rep
, vol.62
, Issue.12
, pp. 2125-2126
-
-
Cavalli, F.1
Tschopp, L.2
Sonntag, R.W.3
Zimmermann, A.4
-
3
-
-
0027238140
-
Hepatotoxicity associated with cisplatin chemotherapy
-
8477119 1:STN:280:DyaK3s3jslKnsQ%3D%3D
-
Cersosimo RJ (1993) Hepatotoxicity associated with cisplatin chemotherapy. Ann Pharmacother 27(4):438-441
-
(1993)
Ann Pharmacother
, vol.27
, Issue.4
, pp. 438-441
-
-
Cersosimo, R.J.1
-
4
-
-
0023293067
-
Cisplatin-induced hepatic toxicity
-
3806175 1:STN:280:DyaL2s7htFOhsA%3D%3D
-
Pollera CF, Ameglio F, Nardi M, Vitelli G, Marolla P (1987) Cisplatin-induced hepatic toxicity. J Clin Oncol 5(2):318-319
-
(1987)
J Clin Oncol
, vol.5
, Issue.2
, pp. 318-319
-
-
Pollera, C.F.1
Ameglio, F.2
Nardi, M.3
Vitelli, G.4
Marolla, P.5
-
5
-
-
38349113990
-
Chemoprotective action of resveratrol and genistein from apoptosis induced in human peripheral blood lymphocytes
-
18092837 10.1080/07391102.2008.10507191 1:CAS:528:DC%2BD1cXht1Ons78%3D
-
Subbiah U, Raghunathan M (2008) Chemoprotective action of resveratrol and genistein from apoptosis induced in human peripheral blood lymphocytes. J Biomol Struct Dyn 25(4):425-434
-
(2008)
J Biomol Struct Dyn
, vol.25
, Issue.4
, pp. 425-434
-
-
Subbiah, U.1
Raghunathan, M.2
-
6
-
-
0029068515
-
The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: Mechanism of the two-electron reduction
-
7568029 10.1073/pnas.92.19.8846 1:CAS:528:DyaK2MXotVGqsb4%3D
-
Li R, Bianchet MA, Talalay P, Amzel LM (1995) The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction. Proc Natl Acad Sci USA 92(19):8846-8850
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, Issue.19
, pp. 8846-8850
-
-
Li, R.1
Bianchet, M.A.2
Talalay, P.3
Amzel, L.M.4
-
7
-
-
4043174109
-
Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin
-
10.1002/ptr.1462 15305308 10.1002/ptr.1462 1:CAS:528:DC%2BD2cXnsFCktLk%3D
-
Psotova J, Chlopcikova S, Miketova P, Hrbac J, Simanek V (2004) Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part III. Apigenin, baicalelin, kaempherol, luteolin and quercetin. Phytother Res 18(7):516-521. doi: 10.1002/ptr.1462
-
(2004)
Phytother Res
, vol.18
, Issue.7
, pp. 516-521
-
-
Psotova, J.1
Chlopcikova, S.2
Miketova, P.3
Hrbac, J.4
Simanek, V.5
-
8
-
-
0031752504
-
Amifostine in reducing cisplatin toxicity
-
9783591 1:CAS:528:DyaK1cXntVaqtb8%3D
-
Markman M (1998) Amifostine in reducing cisplatin toxicity. Semin Oncol 25(5):522-524
-
(1998)
Semin Oncol
, vol.25
, Issue.5
, pp. 522-524
-
-
Markman, M.1
-
9
-
-
0031698016
-
Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy
-
9738590 1:CAS:528:DyaK1cXmtFSlsb0%3D
-
Phillips KA, Tannock IF (1998) Design and interpretation of clinical trials that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy. J Clin Oncol 16(9):3179-3190
-
(1998)
J Clin Oncol
, vol.16
, Issue.9
, pp. 3179-3190
-
-
Phillips, K.A.1
Tannock, I.F.2
-
10
-
-
0029822506
-
Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient
-
8995515 10.1007/s002800050553 1:CAS:528:DyaK2sXis1ajs70%3D
-
Korst AE, Gall HE, Vermorken JB, van der Vijgh WJ (1996) Pharmacokinetics of amifostine and its metabolites in the plasma and ascites of a cancer patient. Cancer Chemother Pharmacol 39(1-2):162-166
-
(1996)
Cancer Chemother Pharmacol
, vol.39
, Issue.1-2
, pp. 162-166
-
-
Korst, A.E.1
Gall, H.E.2
Vermorken, J.B.3
Van Der Vijgh, W.J.4
-
11
-
-
0034998360
-
Amifostine: An update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome
-
11368288 10.2165/00003495-200161050-00012 1:CAS:528:DC%2BD3MXktF2gu74%3D
-
Culy CR, Spencer CM (2001) Amifostine: an update on its clinical status as a cytoprotectant in patients with cancer receiving chemotherapy or radiotherapy and its potential therapeutic application in myelodysplastic syndrome. Drugs 61(5):641-684
-
(2001)
Drugs
, vol.61
, Issue.5
, pp. 641-684
-
-
Culy, C.R.1
Spencer, C.M.2
-
12
-
-
0036176697
-
HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: Implications of dominant platinum-thiol binding to its anticancer action
-
10.1023/A:1014268729658 11883638 10.1023/A:1014268729658 1:CAS:528:DC%2BD38XitVSmu7s%3D
-
Volckova E, Dudones LP, Bose RN (2002) HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: implications of dominant platinum-thiol binding to its anticancer action. Pharm Res 19(2):124-131. doi: 10.1023/A:1014268729658
-
(2002)
Pharm Res
, vol.19
, Issue.2
, pp. 124-131
-
-
Volckova, E.1
Dudones, L.P.2
Bose, R.N.3
-
13
-
-
0036148607
-
Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs
-
11792689 10.1124/dmd.30.2.183 1:CAS:528:DC%2BD38XosFahtQ%3D%3D
-
Sadowitz PD, Hubbard BA, Dabrowiak JC, Goodisman J, Tacka KA, Aktas MK, Cunningham MJ, Dubowy RL, Souid AK (2002) Kinetics of cisplatin binding to cellular DNA and modulations by thiol-blocking agents and thiol drugs. Drug Metab Dispos 30(2):183-190
-
(2002)
Drug Metab Dispos
, vol.30
, Issue.2
, pp. 183-190
-
-
Sadowitz, P.D.1
Hubbard, B.A.2
Dabrowiak, J.C.3
Goodisman, J.4
Tacka, K.A.5
Aktas, M.K.6
Cunningham, M.J.7
Dubowy, R.L.8
Souid, A.K.9
-
14
-
-
79959269452
-
The small-molecule TNF-A modulator, UTL-5g, reduces side effects induced by cisplatin and enhances the therapeutic effect of cisplatin in vivo
-
21699020 1:CAS:528:DC%2BC3MXot1Oqur8%3D
-
Shaw J, Chen B, Huang W-H, Lee A-R, Media J, Valeriote F (2011) The small-molecule TNF-A modulator, UTL-5g, reduces side effects induced by cisplatin and enhances the therapeutic effect of cisplatin in vivo. J Exp Ther Oncol 9(2):129-137
-
(2011)
J Exp Ther Oncol
, vol.9
, Issue.2
, pp. 129-137
-
-
Shaw, J.1
Chen, B.2
Huang, W.-H.3
Lee, A.-R.4
Media, J.5
Valeriote, F.6
-
15
-
-
84861471008
-
Acute toxicity study of cisplatin loaded long-circulating and pH-sensitive liposomes administered in mice
-
22515074 10.1166/jbn.2012.1388 1:CAS:528:DC%2BC38XkvFartb4%3D
-
Leite EA, Lana AM, Junior AD, Coelho LG, De Oliveira MC (2012) Acute toxicity study of cisplatin loaded long-circulating and pH-sensitive liposomes administered in mice. J Biomed Nanotechnol 8(2):229-239
-
(2012)
J Biomed Nanotechnol
, vol.8
, Issue.2
, pp. 229-239
-
-
Leite, E.A.1
Lana, A.M.2
Junior, A.D.3
Coelho, L.G.4
De Oliveira, M.C.5
|